0001209191-20-054842.txt : 20201014 0001209191-20-054842.hdr.sgml : 20201014 20201014192957 ACCESSION NUMBER: 0001209191-20-054842 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201014 FILED AS OF DATE: 20201014 DATE AS OF CHANGE: 20201014 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christian Waage CENTRAL INDEX KEY: 0001553179 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38796 FILM NUMBER: 201240048 MAIL ADDRESS: STREET 1: RECEPTOS, INC. STREET 2: 10835 ROAD TO THE CURE, SUITE 205 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gossamer Bio, Inc. CENTRAL INDEX KEY: 0001728117 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475461709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 922-0718 MAIL ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-14 0 0001728117 Gossamer Bio, Inc. GOSS 0001553179 Christian Waage 3013 SCIENCE PARK ROAD SAN DIEGO CA 92121 0 1 0 0 EVP & General Counsel Common Stock 2020-10-14 4 P 0 2500 9.5272 A 6954 I By family trust Common Stock 547998 D Common Stock 22222 I By trust FBO son This transaction was executed in multiple trades at prices ranging from $9.52 to $9.53 per share. The price reported above reflects the weighted average sale price for the entire number of shares purchased. Information on the exact number of shares purchased at each sale price can be obtained from the Issuer upon request. Includes 141,435 shares subject to forfeiture, which shares will vest in equal monthly installments as set forth in the restricted stock agreement between the Issuer and Reporting Person so that all of the shares will be released from the forfeiture restriction on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Also includes 46,500 restricted stock units granted in February 2020, which shares will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date. /s/ Jeff Boerneke, Attorney-in-Fact 2020-10-14